Veru Reports Positive Clinical Results from VERU-111 Phase 1b/2 Trial in Men with Metastatic Castration-Resistant Prostate Cancer, Advancing to Pivotal Phase 3 Clinical Program
Stock Information for Veru Inc.
Loading
Please wait while we load your information from QuoteMedia.